SUSCEPTIBILITY OF ENTEROCOCCI, METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS AND STREPTOCOCCUS-PNEUMONIAE TO THE GLYCYLCYCLINES

被引:20
作者
WEISS, WJ [1 ]
JACOBUS, NV [1 ]
PETERSEN, PJ [1 ]
TESTA, RT [1 ]
机构
[1] AMER CYANAMID CO,DIV MED RES,INFECT DIS RES SECT,PEARL RIVER,NY 10965
关键词
D O I
10.1093/jac/36.1.225
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in-vitro activities of two glycylcyclines, DMG-MINO and DMG-DMDOT, and several comparative agents were determined against 263 enterococci, 102 methicillin-resistant Staphylococcus aureus and 55 Streptococcus pneumoniae recent clinical isolates. The glycylcyclines and teicoplanin were the most active agents against the enterococcal isolates. All methicillin-resistant S. aureus were susceptible to the glycylcyclines. Only DMG-DMDOT, ciprofloxacin, teicoplanin and vancomycin exhibited comparable activity against penicillin-susceptible, -intermediate and -resistant S. pneumoniae strains.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 11 条
[1]  
[Anonymous], 1993, METHODS DILUTION ANT
[2]  
ELIOPOULO SGM, 1994, ANTIMICROBIAL AGENTS, V38, P534
[3]   IDENTIFICATION OF ENTEROCOCCUS SPECIES ISOLATED FROM HUMAN INFECTIONS BY A CONVENTIONAL TEST SCHEME [J].
FACKLAM, RR ;
COLLINS, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (04) :731-734
[4]   N,N-DIMETHYLGLYCYL-AMIDO DERIVATIVE OF MINOCYCLINE AND 6-DIMETHYL-6-DESOXYTETRACYCLINE, 2 NEW GLYCYLCYCLINES HIGHLY EFFECTIVE AGAINST TETRACYCLINE-RESISTANT GRAM-POSITIVE COCCI [J].
GOLDSTEIN, FW ;
KITZIS, MD ;
ACAR, JF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) :2218-2220
[5]   INCREASING RESISTANCE TO BETA-LACTAM ANTIBIOTICS AMONG CLINICAL ISOLATES OF ENTEROCOCCUS-FAECIUM - A 22-YEAR REVIEW AT ONE INSTITUTION [J].
GRAYSON, ML ;
ELIOPOULOS, GM ;
WENNERSTEN, CB ;
RUOFF, KL ;
DEGIROLAMI, PC ;
FERRARO, MJ ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2180-2184
[6]   INCREASED RATE OF ISOLATION OF PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE IN A CHILDRENS HOSPITAL AND INVITRO SUSCEPTIBILITIES TO ANTIBIOTICS OF POTENTIAL THERAPEUTIC USE [J].
MASON, EO ;
KAPLAN, SL ;
LAMBERTH, LB ;
TILLMAN, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1703-1707
[7]   METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS - A CONSENSUS REVIEW OF THE MICROBIOLOGY, PATHOGENESIS, AND EPIDEMIOLOGY WITH IMPLICATIONS FOR PREVENTION AND MANAGEMENT [J].
MULLIGAN, ME ;
MURRAYLEISURE, KA ;
RIBNER, BS ;
STANDIFORD, HC ;
JOHN, JF ;
KORVICK, JA ;
KAUFFMAN, CA ;
YU, VL .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (03) :313-328
[8]   THE LIFE AND TIMES OF THE ENTEROCOCCUS [J].
MURRAY, BE .
CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (01) :46-65
[9]   GLYCYLCYCLINES .1. A NEW-GENERATION OF POTENT ANTIBACTERIAL AGENTS THROUGH MODIFICATION OF 9-AMINOTETRACYCLINES [J].
SUM, PE ;
LEE, VJ ;
TESTA, RT ;
HLAVKA, JJ ;
ELLESTAD, GA ;
BLOOM, JD ;
GLUZMAN, Y ;
TALLY, FP .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (01) :184-188
[10]   IN-VITRO AND IN-VIVO ANTIBACTERIAL ACTIVITIES OF THE GLYCYLCYCLINES, A NEW CLASS OF SEMISYNTHETIC TETRACYCLINES [J].
TESTA, RT ;
PETERSEN, PJ ;
JACOBUS, NV ;
SUM, PE ;
LEE, VJ ;
TALLY, FP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2270-2277